## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

|<br>FOR THEYEARENDEDsTH A|<br>PRIL 20|<br>23|<br>23||||
|---|---|---|---|---|---|---|
|||UnrestrictedFunds|||||
||Notes|Income<br>Fund<br>EE|Capital<br>Fund|Restricted<br>Fund<br>E|Total<br>2fJ23<br>E|Total<br>2022<br>f|
|Incomeandendowmentsfrom:|||||||
|Investments|||||||
|Dividends received onequities<br>Interestreceivedon other<br>Investments|L7<br>19|53A2L<br>9,996|||s3,42L<br>9,996|51,033<br>9,478|
|Interestreceivedonfixedinterest|||||||
|stocks<br>Stockbrokers accountinterest|18<br>|13,163<br>351|||13,163<br>351|12,631<br>0|
|Totalincome||76,93L||o|76,931|73,082|
|Expenditureon:<br>Raising funds|6||LO,73l||to,73t|15,286|
|Charitable activities|2|64,672|||64,672|43,098|
|Total expenditure||64,672|LO,73L|o|75,4O3|58,384|
|Netincome/(expenditure)||L2t259|(10,731)|0|1,528|74,698|
|Transfer between funds|||||o|0|
|||L2t259|(LO173L)|o|1,528|14,698|
|Gains/(losses)on investmentassets<br>Unrealised<br>t7-L9<br>Realised<br>L7-Lg|||(85,91O)<br>(6,011)||(85,91O)<br>(6,O11)|248,944<br>4,772|
|||o|(91,921)|o|(91,921)|253,656|
|NetMovementInFunds||L2,259|(102,652)|o|(90,393)|268,354|
|ReconciliationofFunds|||||||
|TotalFundsbrought forward|||||1,982,031|7,773,677|
|TotalFundscarriedforward||269t823||,576,OOL|45,8L4|1,891,639|1,982,031|





## 

||Notes|2lJ23|||2022||
|---|---|---|---|---|---|---|
|||E|E|f||f|
|Fixed assets|||||||
|Investments:|||||||
|Equities|t7||L,253t639|||1,349,559|
|Fixed income stocks|18||L94,979|||270,854|
|Other investments|19||372,434|||381,298|
||||1,821,O52|||1,941,711|
|Currentassets|||||||
|Debtors|11|o||0|||
|Cashatbank andwithstockbrokers||72,883||47,976|||
|Total Currentassets||72,883||41,916|||
|Liabilities|||||||
|Creditors: Amounts falling duewithinone year|t2|2,297||7,596|||
|NetCurrentassets|||7Ot5l'6|||40,320|
|Net assets|||1,891,638|||1,982,037|
|Thefunds of the charity:|13||||||
|Unrestricted funds:|||||||
|Capitalfund|||tt576,OOL|||1,678,653|
|Incomefund|||269,823|||257,564|
|Restricted fund|||45,814|||45,814|
|Total charity funds|||1,891,638|||1,982,037|





## 

## 

## 

## 

## 

## 

## 

## 

## 

||zfJ23|2022|
|---|---|---|
|2.CharitableActivities|E|E|
|Researchprojects|57,5O4|37,548|
|Othercosts|5,236|3,954|
|Governance costs|L,932|7,596|
||64,672|43,098|





## 

|<br>OTES TO THEACCOUNTS<br>OR THEYEAR ENDEDsTH|<br>(CONTINUED)<br>APRIL 2023|||
|---|---|---|---|
|||2lJ23|2022|
|||E|€|
|ResearchProjects||||
|NIHR CastangFoundationAdvanced Fellowship Award||||
|DrAlexandra Hendry, University of Oxford-Refining, testing and targeting||||
|an interventiontosupporttheearly developmentofExecutiveFunctions<br>amongst infantsatelevated likelihood of autism and/orADHD||42,600|31,092|
|||42,600|31,092|
|BACDFundingAward-RAISE|ResearchingAllied Health inSchoolsand|||
|Education||||
|NewcastleUniversity|Researchstaffand|||
||runningcosts|0|0|
|||o|o|
|IanCrockerStudy-A Heme-Binding Agent forthePrevention ofFetal||||
|Vascular Compromise||||
|ManchesterUniversity||6t27L|0|
|||6,27L|0|
|Supportcosts||81533|6,456|
|||57,504|37,548|



## 



## 

|||2023|2022|
|---|---|---|---|
|||E|f|
|5,|Supportcosts|||
||Trustees'expenditure:|||
||Researchintoprojects beingconsidered|||
||by the Trustees and monitoring those|||
||supported by the charity<br>Raisingfunds|8,633<br>lo,73L|6,456<br>75,286|
||Governance costs|1,932|1,596|
|||2Lt296|23,338|
||Allocatedasfollows:|||
||Grants and research projects|9,633|6,456|
||Raisingfunds|1o,731|15,286|
||Governance costs|L,932|1,596|
|||2L,296|23,338|



||<br>charges are attributabletosupportcostswith thebalanceattr<br>administration.|<br>ibutable tomanagementand||
|---|---|---|---|
|6.|Raisingfunds|||
||Investmentmanagementcosts:|||
||Stockbroker'snominee fees|8,321|73,342|
||Administrativefees|2ALO|7,944|
|||LO,73L|15,286|
|7|Othercosts|||
||Bankcharges and interest|L2|30|
||Printing, stationeryandwebsitecosts|388|120|
||Management and administrativefees|4,836|3,804|
|||5,236|3,954|
|8.|Governance costs|||
||Accountancycharges|996|972|
||Independent examiner'scharges|936|624|
|||L,932|1,596|



## 

## 

## 



## 

|<br>FOR THEYEARENDEDsTH APR|IL 2023|||||
|---|---|---|---|---|---|
|||Fixed||||
|||Income|Other|Total|Total|
|10.Investments<br>Quotedinvestments|Equities<br>E|Stocks<br>E|Investments<br>E|zlJ23<br>E|2022<br>f|
|(see notes 17,18&19)<br>Market valueat6thApril2O22|1r3491559|10,<br>2<br>54|381,298|lt94l,7lL|1,693,943|
|Additions during the year<br>Disposalsduring the year|6O,OO5<br>(94t7s4)|o<br>o|o<br>o|6O,OO5<br>(94t754)|88,461<br>(89,637)|
|Net unrealised investment<br>gains/(losses)|(6Ll7L)|(15,87s)|<br>(8,864)|(8s,910)|248,944|
|Market valueat5th April2023|1,253,639|L94,979|<br>372,434|t,82l,O52|7,941,777|
|Historical costasat5t||||||
|April2O23|853,859|206,481|<br>287,039|1,347t378|7,320,167|



## 

## 

|Statement of fun|ds||||||
|---|---|---|---|---|---|---|
||Balanceat<br>06.o4.2022|Incoming<br>Resources|Resources<br>Expended|Netgains/<br>(losses)|Transfers|Balanceat<br>o5.04.2023|
||E|E|E||E|E|
|Unrestricted funds|||||||
|Income fund|||||||
|General<br>CapitalFund|257,564<br>1,678,653|76,93L<br>o|(64,672)<br>(ro,73L)|o<br>(91,921)|o<br>o|269,823<br>1,576,0O1|
||1,936,217|76t93L|(75,403)|<br>(91,921)|o|L,845,824|
|Restricted funds|||||||
|BACDfund|4s$L4|o|o|o|o|45t8L4|
||45,814||o|o|o|45,814|
|Total funds|lrgg2r031|76,93t|(75,403)|<br>(91,92L)|o|1,891,638|





## 

|||||
|---|---|---|---|
|FutureCommitments|||Future|
||Total|Commitment||
||Cost||at5.4.23|
||E||E|
|TheTrusteeshaveagreedtofundthefollowing projects:||||
|a.BACD|175,OOO||175,OOO|
|b.BACD(Restricted)|lSo,ooo||45,814|
|c.UniversityofManchester- IanCrockerStudy|165,655||52,559|
|d.NIHRCastang Foundation AdvancedFellowship Award|190,1O1||116,408|
||||389,781|



## 

## 

## 

## 

## 

||UnrestrictedFunds|UnrestrictedFunds||||
|---|---|---|---|---|---|
||Income<br>Fund<br>EE|Capital<br>Fund|Restricted<br>Funds<br>E|Total funds<br>2lJ23<br>E|Total funds<br>2022<br>E|
|Fixedasset investments|245,O51|L,576tOOt|o|I,82I,O52|7,941,771|
|Currentassets<br>Creditors|27,lJ69<br>(2t297)|o<br>o|45,814<br>o|72,883<br>(2,297)|47,916<br>(1,596)|
||269,823|l,576,0()1|45,8L4|1,891,638|1,982,O37|





## 

## 

|Comparative StatementofFinancialActivi|ties||||
|---|---|---|---|---|
||Unrestricted|Funds|||
||Income<br>Fund<br>EC|Capital<br>Fund|Restricted<br>Fund<br>E|Total<br>zlJ22<br>C|
|Incomeandendowmentsfrom:|||||
|Investments|||||
|Dividends received on equities|51,033|||51,033|
|Interestreceived on other|||||
|Investments|9,479|||9,418|
|Interestreceivedonfixedinterest|||||
|stocks|72,631|||72,637|
|Totalincome|73,082|0|0|73,082|
|Expenditureon:|||||
|Raisingfunds||15,286||15,286|
|Charitable activities|43,098|||43,098|
|Total expenditure|43,098|75,286|0|58,384|
|Net income/(expenditure)|29,984|(15,286)|0|14,698|
|Transfer between funds||||0|
||29,984|(15,286)|0|14,698|
|Gains/(losses)oninvestmentassets|||||
|Unrealised||248,944||248,944|
|Realised||4,772||4,772|
||0|253,656|o|253,656|
|NetMovementfnFunds|||0|268,354|
|ReconciliationofFunds<br>TotalFundsbrought forward|224580|1,440,283|45,874|7t713,677|
|TotalFundscarriedforward|257,564|7,678,653|45,874|7,992,037|





## 

|Investments-Equities||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Heldwithin theU,K.|At 6thApril2022<br>Market<br>Number<br>Value<br>E||Acquisitions<br>Number<br>Cost<br>E|||Sales<br>NumberProceeds<br>E|||Realised<br>Gains/<br>(Losses)<br>E|Unrealised<br>Gains,/<br>(Losses)<br>€|At 5thApril2023<br>Market<br>Number<br>Value<br>E||Historical<br>Cost<br>E|Date|Dividend<br>Received<br>f|
|AstraZeneca<br>Ordinary25p Shares|1,OOO|1O3,340|||23.O8.2022||3OO|3?,720|(2t7LA)|L4,256|7lJlJ|41,158|21,L97|sep<br>lvlar|764.OO<br>1,139.60|
|BAESystems<br>Ordlnary2.5pShares|8,5OO|62,968||||||||zL,6(J7|a,5oo|a4,s7s|37,744|lun<br>Nov|1,292,00<br>a84.OO|
|British American Tobacco<br>Ord 25p shares|1,470|6(J,373||||||||(7,e19)|\47,J|52,454|5O,235|May<br>Aug|1,01a.22<br>1,O18.22|
|||||||||||||||Nov|r,018,22|
|||||||||||||||Feb|\oLa.22|
|BP<br>Ordinary 0.25US$ Shares|12,OO0|45'94A||||||||14,096|12,OO0|64,044|5',597|Jun<br>sep|522,67<br>62().21|
|||||||||||||||Dec|592,a2|
|||||||||||||||Mar|566.O8|
|Diageo<br>ordinary 28totTrorpShares|2,3OO|91,52a|||23.O4.2022||300|Lt492|(446)|(6,21O)|2,OOO|73,34O|12,84O|Apr<br>Oct|675,2A<br>936,40|
|Digital9 Infrastructure<br>OrdNPV|34,o95|42,4OO||||||||(t6,s72)|38,O95|2s,82A|4').275|Jun<br>sep|s71,43<br>571,43|
|||||||||||||||Dec|571,43|
|Foresight Solar FundLtd<br>NPV|4O,00o|44t4AO||||||||(32O)|40,OO0|44,16lJ|39,949|lvlar<br>lvlay<br>Au9|57t,43<br>694,00<br>7L2.OO|
|||||||||||||||Nov|7L2,OO|
|||||||||||||||Feb|7t2,OO|
|GSK<br>Ordinary25pShares|5,OOO|a5,190|(1s,469)<br>(Demerger of||<br> Haleon Group|1,OOO<br> 1:1)||o|(1,56e)|(8,664)|<br>4,OOO|s9,4a8|63,143|Apr<br>Jul<br>Oct<br>Jan|1,15O.00<br>700.oo<br>650.OO<br>550.O0|
|Haleon Group<br>Ordinary €1.25shares<br>ImpactHealthcare Reit<br>Ordinary1p shares|3a,ooo|46,056|5,OOO<br>L5,46902.Oa.2O22<br>(Demerger outof GSK1:1)|||5,OOO||15,150|(319)|(10,716)|38,OOO|3s,34O|39,s99|May<br>sep|521,30<br>621,30|
|||||||||||||||Nov|621,30|
|||||||||||||||Feb|621,30|
|JPMorqan Global CoreRealAssets<br>OrdNPV|4O,O0O|37,600||||||||(3,360)|4O,OO0|34,24lJ|40,275|May<br>Au9|400.oo<br>400,oo|
|||||||||||||||Nov|400,00|
|||||||||||||||Apr|344.45|
|Land Securities<br>Ordinary 10.6666666pShares|4,570|35,a65||||||||(7.668)|<br>457lJ|2A,t97|24,094|Feb<br>Jan<br>Jul|420.00<br>411,30<br>594,10|
|||||||||||||||Oct|393.O2|
|Carriedforuard||655,748||||||60,362|(s,Os2)|<br>(7,47lJ)||542,464|420,992||26,227,73|





## 

|Investments'Equities(Continue|d)|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Heldwithin theU.K,<br>Broughtforuard|At 6th April<br>Number|2022<br>Market<br>Value<br>E<br>655,748|Acquisitions<br>Number<br>Cost<br>E<br>o||Sales<br>NumberProceeds<br>E<br>6O,362||Realised<br>Gains,/<br>(Losses)<br>E<br>(s,os2)|Unrealised<br>Gains/<br>(Losses)<br>E<br>(7,47O)|At sth April2023<br>Market<br>Number<br>Value<br>EE<br>582,864||Historical<br>Cost<br>420'992|Date|Dividend<br>Received<br>E<br>26,227.73|
|Legal & General<br>Ordinary272p Shares|24,OOO|65,44A||||||(9,O96)|24,OOO|56,352|34,67O|Jun<br>sep|3,184.aO<br>1,3O5.6O|
|M.P. Evans Group<br>Ordinary 10pShares|||05.01.20233,600|29,454||||2.226|3,6OO|31,680|29,454|||
|PRSReit (The)<br>Ordinary1p shares|29,2.J5|31,a33||||||(8,148)|29,2O5|23,585|29,42.6|lvlay<br>Auq|292.O5<br>292,O5|
|||||||||||||Nov|292,05|
|||||||||||||lvlar|292.O3|
|RELXGroup<br>Ordinary 14 51/116pShares|4,6OO|L12,47O|||1,200 28,381||(9s9)|6,120|3,40O|89,250|22,OOt|Jun<br>sep|1,533.OO<br>722.20|
|SDCLEnergy Efficiency Income Trust<br>Ordianry1pshares|40,OOO|4A,4AO||||||(14,16O)|4O,0OO|34,3zlJ|4lJ,677|Jun<br>sep|552.OO<br>600,oo|
|||||||||||||Dec|600.oo|
|||||||||||||Mar|600.oo|
|Shell<br>OrdinaryEuro0.7|3,OOO|53,530||||||7,26.)|3.OOO|7O,a9O|<br>39,095|Jun<br>sep<br>Dec|600.30<br>647.1O<br>514,30|
|||||||||||||Mar|723.30|
|Supermarket IncomeREIT<br>Ordinary1p Shares|35,O0O|46.aO0||||||(16,344)|36,000|30,456|37,161|May<br>Aug|534.60<br>534.60|
|||||||||||||NoV|540.OO|
|||||||||||||Feb|540.OO|
|Unilever<br>Ordinary3l/npShares|L,7OO|6O,L2t||||||t2,7A4|\7OO|72,9lJ5|t5,457|Jun<br>sep|610.30<br>6L7.6L|
|||||||||||||Dec|632.74|
|||||||||||||Mar|648.O4|
|Vodafone<br>Ordinary US90.2095238<br>shares|29,OOO|36,389||||||(10,449)|Z9,0OO|<br>2',940|45233|Aug<br>Feb|I,O97,69<br>t,L48,17|
|Held OutsidetheU.K.||||||||||||||
|Roche Holdings AG||||||||||||||
|Genusscheine NPV (NES)|300|94,4O5||||||(23,616)|300|7L,tA9|to,374|lvlar|1,514,49|
|Samarang Asset ManaqementS.A.<br>Asian ProsperityA1|L43|38,460||||||(762)|L43|t7.69a|41,O42|Dec|1,684,54|
|Schrcder Oriental<br>Ordinary1p Shares|35,O0O|95,375||||||(s,775)|35,OOO|89,6O0|t7,726|May<br>Aug<br>Nov|65s.OO<br>700.oo<br>1,96O.OO|
|UniversalMusicGroup<br>Euro10 shares|||(2r.7O.2O22)l.aso|3o,ss1||||6,259|1,a5O|36,a10|3O,551|Feb|700.oo|
||1,349,559|||6O,OO5|88,743||(6,011)|<br>(6'-,171'||1,253,639|853,a59||s3A2O,7L|





|18, Investments -FixedIncome|stocks||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
||At 6th April<br>Number<br>EE|2022<br>Market<br>value|Acquisitions<br>Number<br>Cost<br>EE|||Sales<br>NumberProceeds<br>EE||Realised<br>Gains,/<br>(Losses)<br>€|lJnrealised<br>cains/<br>(Losses)<br>E|At sth April2023<br>Market<br>Number<br>Value<br>EEE||Historical<br>Cost|Date|Income<br>R*eived<br>E|
|CGPortfiolioFund<br>The DollarFund CLS'D'|3O0|5L.942|||||||(1,9s9)|<br>3Oo|49,9A3|48,1a6|Nov|508.1S|
|CQS NewCityHighYield FundLtd<br>OrdinaryShares<br>IOO,OOO||53,7OO|||||||(s,o50)|loo,ooo|48,650|52,388|tvtay<br>Au9|1,OOO.0O<br>1,48O.OO|
||||||||||||||Nov|1,OOO.OO|
||||||||||||||Feb|1,OOO,OO|
|GCPlnfrastructureInvestments<br>OrdinaryC€0.01|Ltd<br>15,291|L7.LA7|||||||(3,960)|15,291|'-3,227|16,O95|lun<br>sep<br>Dec|267,s9<br>267.59<br>267,59|
||||||||||||||lvlar|267.59|
|InvescoBondIncomePlus<br>OrdinaryNPV|3O,OOO|5:Jt175|||||||(4,OsO)3O.OOO||<br>49,L25|s5,L47|14ay<br>Aug|a25.OO<br>825.OO|
||||||||||||||Nov|462.50|
|Held OutsidetheU.K.|||||||||||||Feb|862.50|
|Biopharma Credit<br>OrdLJSDo.01 Shares|44.OOO|34,a5O|||||||(855)|44,OOO|<br>33,994|34,665|May<br>sep|511.63<br>649.15|
||||||||||||||Nov|2,36a.25|
|||2totaB4|||o||o||(1s,87s)||t94t979|2O6'4AL||13,L52.54|
|19. Investments - Other|||||||||||||||
|Heldwithin theU.K.|At 6th April<br>Number|2022<br>Market<br>Value<br>E|Acquisitions<br>Number<br>Cost<br>E|||Sales<br>NumberProceeds<br>€||Realised<br>Gains/<br>(Losses)<br>2|Unrealised<br>Gains/<br>(Losses)<br>E|E<br>Number<br>At5thApril2023<br>Market<br>Value||E<br>Historical<br>Cost|Date|Dividend<br>Received<br>€|
|Bny l4ellonN4anagersLtd<br>Real Return|39,OO0|44,6s5|||||||(2,ss 1)|39,OOO|42tLO4|39,935|sep<br>Feb|421,50<br>490,20|
|Charities PropertyFund<br>IncomeShares|50,ooo|54,545|||||||(s,39s)|5O,OOO|63,190|60,120|May<br>Aug|717,71<br>617,75|
||||||||||||||Nov|523.45|
||||||||||||||Feb|565.55|
|Ruffer InvestmentCompany<br>Red PtgPref.0001pShares|24,OOO|74,O4O|||||||L2O|24,OOO|74tt6o|3O,814|Oct<br>Mar|300.oo<br>324.OO|
|Held OutsidetheU.K.|||||||||||||||
|LinkFundSolutionsLtd<br>Trojan Global lncomeOInc|7a,ooo|Lo5,2t4|||||||(6,326)|7a,OOO|9a,aaa|49,342|Jun<br>sep|937.25<br>754.34|
||||||||||||||Jan|843.65|
||||||||||||||Mar|595.OA|
|VeritasFund<br>Global Equity IncomeSterlin(|<br>4OO|88,804|||||||5,288|400|94,O92|66,828|Apr<br>Oct|861.52<br>1,842.6a|
|||341,298|||o||o||(8,864)||372,434|2A7,O39||9r995.O8|





## 

## 

## 

## 

